NTRA
NTRA
NASDAQ · Biotechnology

Natera Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$259.97
+25.21 (+10.74%)
As of Jun 24, 9:38 PM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 24 89%
Hold 3 11%
Sell 0 0%
Price Target
Analyst Price Target -45.0% upside
Low Target $88.14
Average Target $142.91
High Target $188.78
Current Price $259.97
Current
$259.97
Target
$142.91
$88.14 $142.91 avg $188.78
Scenario Analysis
Bear Case
$88.14
-66.1%
Low target
Base Case
$142.91
-45.0%
Avg target
Bull Case
$188.78
+-27.4%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$256.36
1.4% from high
52-Week Low
$131.81
+97.2% from low
50-Day SMA
$229.31
+13.4% vs SMA
200-Day SMA
$186.42
+39.5% vs SMA
RSI (14)
38.6
Neutral
Target vs 52W High
$142.91
-44.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%